Patents by Inventor Pin-Ju Chueh

Pin-Ju Chueh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7053188
    Abstract: Compositions and methods for diagnosis of neoplastic tissue are described. Monoclonal antibodies which specifically recognize the tumor cell specific NADH:protein thiol reductase and the hybridoma cell lines which produce them are provided. Also provided are diagnostic and immunohistological assays for the identification of cells that are neoplastic.
    Type: Grant
    Filed: February 24, 2003
    Date of Patent: May 30, 2006
    Assignee: Purdue Research Foundation
    Inventors: D. James Morré, NaMi McCarty, Dorothy Morré, Pin-Ju Chueh
  • Publication number: 20030207340
    Abstract: The present disclosure provides the nucleotide sequence encoding a cell surface NADH oxidase/protein disulfide-thiol interchange protein (tNOX) characteristic of neoplastic and virus-infected cells. Also provided are recombinant DNA molecules comprising a sequence portion encoding full length or truncated tNOX, recombinant host cell which express full length or truncated tNOX, methods for recombinant production of tNOX or truncated tNOX, and diagnostic methods which employ either nucleotide sequences of the neoplastic cell-specific tNOX or antibodies specific for the rNOX protein.
    Type: Application
    Filed: May 1, 2002
    Publication date: November 6, 2003
    Inventors: D. James Morre, Dorothy M. Morre, Pin-ju Chueh
  • Publication number: 20030170757
    Abstract: Compositions and methods for diagnosis of neoplastic tissue are described. Monoclonal antibodies which specifically recognize the tumor cell specific NADH:protein thiol reductase and the hybridoma cell lines which produce them are provided. Also provided are diagnostic and immunohistological assays for the identification of cells that are neoplastic. Because the antibodies specifically prevent the growth of cancer cells, induce apoptotic cell death of cancer cells, and are without effect on normal cells, the described monoclonal antibodies are useful for inhibiting cancer cell growth and for treating a neoplastic condition.
    Type: Application
    Filed: February 24, 2003
    Publication date: September 11, 2003
    Inventors: D. James Morre, NaMi McCarty, Dorothy Morre, Pin-Ju Chueh